Medication Treatment for Pericarditis
The first-line medication treatment for pericarditis consists of high-dose aspirin or NSAIDs plus colchicine, with treatment continued until complete symptom resolution and normalization of inflammatory markers. 1, 2
First-Line Treatment
NSAIDs/Aspirin
- Aspirin: 500-1000 mg every 6-8 hours (1.5-4 g/day)
- Ibuprofen: 600 mg every 8 hours (1200-2400 mg/day)
- Indomethacin: 25-50 mg every 8 hours (start at lower doses and titrate upward)
- Treatment duration: Weeks to months until symptoms resolve and CRP normalizes 1
- Tapering: Decrease doses gradually (e.g., aspirin by 250-500 mg every 1-2 weeks) 1
Colchicine (Add to NSAIDs/Aspirin)
- Dosing: 0.5 mg twice daily for patients ≥70 kg or 0.5 mg once daily for patients <70 kg 1
- Duration: At least 6 months 1
- Benefits: Reduces recurrence rate from 15-30% to 8-15% 2, 3
- No loading dose is recommended 1
Treatment Considerations by Etiology
Idiopathic/Viral Pericarditis (most common in developed countries):
Tuberculous Pericarditis (most common in endemic areas):
Bacterial Pericarditis:
Neoplastic/Autoimmune Pericarditis:
Second-Line Treatment: Corticosteroids
Only use when:
- Incomplete response to aspirin/NSAIDs and colchicine
- Contraindications to NSAIDs (allergy, recent peptic ulcer, high bleeding risk)
- Specific indications (systemic inflammatory diseases, pregnancy) 1
Dosing: Prednisone 0.2-0.5 mg/kg/day 1
Important caveat: Corticosteroids should be added to aspirin/NSAIDs and colchicine as triple therapy, not replace them 1
Tapering: Very slow decrements (1.0-2.5 mg) at intervals of 2-6 weeks, especially at the critical threshold of 10-15 mg/day 1
Treatment for Refractory Recurrent Pericarditis
- For multiple recurrences unresponsive to conventional therapy, IL-1 blockers have demonstrated efficacy 3, 4
- IL-1 blockers (anakinra, rilonacept) significantly reduce recurrences compared to placebo (10% vs 78%) 4
Monitoring and Follow-up
Continue treatment until:
- Complete resolution of symptoms
- Normalization of CRP
- Resolution of ECG changes
- Resolution of pericardial effusion (if present) 2
Follow-up visits: Every 1-2 weeks initially, then every 1-2 months until treatment completion 2
Common Pitfalls to Avoid
Premature discontinuation of treatment before symptoms and inflammatory markers normalize (leading cause of recurrence) 2
Inadequate dosing of NSAIDs - full anti-inflammatory doses should be given every 8 hours 2
Using corticosteroids as first-line therapy - associated with higher recurrence rates 1, 2
Rapid tapering of medications - particularly corticosteroids, which requires extremely slow tapering 1
Failure to add colchicine - doubles the risk of recurrence 1, 3